跳至主要内容
临床试验/NCT06462924
NCT06462924撤回1 期

Feasibility of Gadolinium Contrast Reduced Brain MRI: the Potential of Deep Learning

DeepMeds0 个研究点目标入组 101 人开始时间: 2024年8月30日最近更新:
适应症

试验速览

阶段
1 期
状态
撤回
发起方
入组人数
101
主要终点
Vessel conspicuity

研究概览

简要总结

MRI scans were performed using 3 different 1.5T scanners with an eight-channel head coils. Following a 3D pre-contrast T1w scan, a low-dose contrast-enhanced 3D T1w scan was obtained using 20% (0.02 mmol/kg) of the standard dosage of gadoterate meglumine.

The subjects were immediately administered the remaining 80% (0.08 mmol/kg) of the contrast agent to reach the standard dose of 0.1 mmol/kg, which served as a training ground truth for further quantitative assessment. All three acquisitions were performed during a single imaging session, with no additional gadolinium dose administered above the standard protocol.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical indications for imaging with a contrast-enhanced 3D-T1w MRI sequence including tumor suspicion, postoperative tumor follow-up, multiple sclerosis, routine brain imaging, etc.,
  • no plan for dynamic contrast administration or deviation from the standard dose of 0.1 mmol/kg body weight (e.g., sella imaging, magnetic resonance angiography),
  • no clinical contraindications to imaging prolongation (i.e., emergency, poor patient condition).

排除标准

  • prominent image artifacts,
  • incomplete study sequences (e.g., early termination)
  • errors related to contrast agent administration.

结局指标

主要结局

Vessel conspicuity

时间窗: 1 Day After MRI session

(0) no normal vessels observed, (1) significant decrease in conspicuity with potential impact on diagnosis, (2) mild decrease in conspicuity with unlikely impact on diagnosis, (3) normal conspicuity, (4) mild increase in conspicuity with unlikely impact on diagnosis, and (5) significant increase in conspicuity with potential impact on diagnosis.

Image quality

时间窗: 1 Day After MRI session

Image quality using a 5-point Likert scale covering 1 (none), 2 (poor), 3 (moderate), 4 (good), and 5(excellent) ratings

次要结局

  • Enhancement pattern(1 Day After MRI session)

研究者

发起方
DeepMeds
申办方类型
Industry
责任方
Sponsor

相似试验